PMS17 BUDGET IMPACT OF NEW RHBMP-2 FORMULATION IN PATIENTS UNDERGOING POSTEROLATERAL SPINAL FUSION PROCEDURES FOR DEGENERATIVE DISC DISEASE IN RANDOMIZED CONTROLLED TRIAL (RCT)
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)72170-2
https://www.valueinhealthjournal.com/article/S1098-3015(11)72170-2/fulltext
Title :
PMS17 BUDGET IMPACT OF NEW RHBMP-2 FORMULATION IN PATIENTS UNDERGOING POSTEROLATERAL SPINAL FUSION PROCEDURES FOR DEGENERATIVE DISC DISEASE IN RANDOMIZED CONTROLLED TRIAL (RCT)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72170-2&doi=10.1016/S1098-3015(11)72170-2
First page :
A305
Section Title :
RESEARCH POSTER ABSTRACTS
Open access? :
No
Section Order :
331